Kelly Shi
Stock Analyst at Jefferies
(2.44)
# 2,540
Out of 5,044 analysts
32
Total ratings
43.33%
Success rate
3.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $129 → $148 | $165.07 | -10.34% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $16.11 | +73.81% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $19.25 | +128.57% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $8.79 | +70.65% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $19.46 | +167.21% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.57 | +206.35% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $24.99 | -23.97% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $205.31 | -4.53% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $4.75 | +342.11% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $13.77 | +168.70% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $3.04 | +97.37% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $68.00 | -32.35% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $92.68 | -12.60% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.80 | +76.81% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.80 | +1,185.71% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $10.00 | +60.00% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $61.17 | -34.61% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $12.51 | +59.87% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.59 | +208.88% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.86 | +3,034.07% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $14.73 | +253.02% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $1.58 | +1,608.64% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.77 | +1,764.41% | 1 | Mar 8, 2021 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $165.07
Upside: -10.34%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $16.11
Upside: +73.81%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $19.25
Upside: +128.57%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $8.79
Upside: +70.65%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $19.46
Upside: +167.21%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.57
Upside: +206.35%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $24.99
Upside: -23.97%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $205.31
Upside: -4.53%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $4.75
Upside: +342.11%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $13.77
Upside: +168.70%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $3.04
Upside: +97.37%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $68.00
Upside: -32.35%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $92.68
Upside: -12.60%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $19.80
Upside: +76.81%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.80
Upside: +1,185.71%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $10.00
Upside: +60.00%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $61.17
Upside: -34.61%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $12.51
Upside: +59.87%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.59
Upside: +208.88%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.86
Upside: +3,034.07%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $14.73
Upside: +253.02%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $1.58
Upside: +1,608.64%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.77
Upside: +1,764.41%